Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • demold
    Junior Member
    • Aug 2013
    • 1

    RNASeq de novo from TopHat unmapped.bam

    I ran a RNASeq pipeline for human skin samples using TopHat2 and hg19 as the reference genome and, because I wanted to find contaminants from other organisms, I used the reads contained in unmapped.bam as input (after convert them to fastq files) for de novo RNASeq with Trinity.

    I don't understand why some contigs generated by Trinity map with 100% identity in about 3000 bp alignment to ensembl transcripts.

    Why the reads from which that contigs were generated were in unmmaped.bam file produced by TopHat?

    Any idea?
  • Zunaira
    Junior Member
    • Dec 2017
    • 1

    #2
    Hi,

    I read your post. I am also trying to construct a de novo assembly using unmapped.bam files from TopHat but I am getting errors. Did you sort your .bam reads before converting them to fastq? I know you did it long time ago but Can you please help me by sharing the steps?

    Comment

    • offspring
      Member
      • Mar 2013
      • 32

      #3
      Hi Zunaira,

      you haven't stated the exact problems you see, but TopHat unmapped.bam files generally contain several errors that can impede processing.

      We published a software called TopHat-Recondition to fix these errors a while ago, please see the paper and the software.

      Let me know in case you have questions.

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Yesterday, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...